FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4379330255> ?p ?o ?g. }

• W4379330255 endingPage "e15573" @default.
• W4379330255 startingPage "e15573" @default.
• W4379330255 abstract "e15573 Background: HER2 is a well-established biomarker and target in multiple tumor types, including metastatic colorectal cancer (mCRC). Despite the lack of HER2 amplification, certain HER2-low tumors were recently found to respond to novel HER2-directed antibody-drug conjugates, warranting an exploration of the clinical and molecular features of these entities. Yet, the real-world prevalence and the clinicopathologic characteristics of HER2-low mCRC are largely unknown. Here, we aim to describe the features of HER2-low mCRC and compare them to HER2-0 colorectal tumors. Methods: We retrospectively reviewed clinicopathologic data from consecutive patients with mCRC undergoing HER2 testing (immunohistochemistry [IHC] and in-situ hybridization [ISH], when appropriate) between 2017 and 2021 at Hadassah Medical Center, Israel. Tumors were defined HER2-positive (HER2+) if scored IHC 3 + or IHC 2+/ISH positive; HER2-low if scored IHC 2+/ISH negative or IHC 1+; HER2-0 if scored IHC 0. Genomic alterations were determined through a targeted next-generation sequencing (NGS) panel. Clinicopathologic and genomic data were compared between the cohorts with the Mann-Whitney or Fisher's exact test, and survival using Log-rank test. Results: A total of 100 consecutive mCRC patients were found eligible for our study, including 4 (4%) with HER2+, 30 (30%) with HER2-low, and 66 (66%) with HER2-0 disease. In the HER2-low group, five tumors were HER2 +2 / ISH negative, and 25 were scored HER2 +1. The fraction of female patients was 40% in HER2-low group, and 42% in the HER2-0 cohort (p > 0.99). The prevalence of mismatch repair deficient (MMR-D) tumors was also similar, with one MMR-D tumor in the HER2-low group, compared to 3 tumors in the HER2-0 (p > 0.99). 60% of the primary tumors in both groups originated in the left colon and rectum. Also, the prevalence of mucinous histology was comparable between the HER2-low and the HER2-neg cohorts (7.4% vs. 4.8%, p = 0.64). Among patients receiving local somatic NGS testing (n = 61), the fractions of patients with KRAS, BRAF, and TP53 mutations were largely comparable between the cohorts (Table 1). With a median follow up of 37 months, the median overall survival was 41 months for the HER2-low group and 51 months for the HER2-neg group (p = 0.15). Conclusions: In our cohort of patients with HER2-negative mCRC, the clinicopathologic and genomic characteristics of HER2-low and HER2-0 tumors did not differ significantly. However, our data suggest that HER2-low tumors represent a significant portion of mCRC, supporting further development of novel HER2-directed therapies for this population. Additionally, our data also support the notion that HER2-low, as currently defined, is not a distinct molecular subtype of mCRC. [Table: see text]" @default.
• W4379330255 created "2023-06-05" @default.
• W4379330255 creator A5011843422 @default.
• W4379330255 creator A5021715818 @default.
• W4379330255 creator A5027545866 @default.
• W4379330255 creator A5071651097 @default.
• W4379330255 creator A5092084819 @default.
• W4379330255 date "2023-06-01" @default.
• W4379330255 modified "2023-09-25" @default.
• W4379330255 title "Clinical and molecular characterization of HER2-low metastatic colorectal cancer." @default.
• W4379330255 doi "https://doi.org/10.1200/jco.2023.41.16_suppl.e15573" @default.
• W4379330255 hasPublicationYear "2023" @default.
• W4379330255 type Work @default.
• W4379330255 citedByCount "0" @default.
• W4379330255 crossrefType "journal-article" @default.
• W4379330255 hasAuthorship W4379330255A5011843422 @default.
• W4379330255 hasAuthorship W4379330255A5021715818 @default.
• W4379330255 hasAuthorship W4379330255A5027545866 @default.
• W4379330255 hasAuthorship W4379330255A5071651097 @default.
• W4379330255 hasAuthorship W4379330255A5092084819 @default.
• W4379330255 hasConcept C104317684 @default.
• W4379330255 hasConcept C121608353 @default.
• W4379330255 hasConcept C126322002 @default.
• W4379330255 hasConcept C142724271 @default.
• W4379330255 hasConcept C143998085 @default.
• W4379330255 hasConcept C191093355 @default.
• W4379330255 hasConcept C204232928 @default.
• W4379330255 hasConcept C2777542201 @default.
• W4379330255 hasConcept C2779786085 @default.
• W4379330255 hasConcept C2781187634 @default.
• W4379330255 hasConcept C2781197716 @default.
• W4379330255 hasConcept C30481170 @default.
• W4379330255 hasConcept C526805850 @default.
• W4379330255 hasConcept C530470458 @default.
• W4379330255 hasConcept C55493867 @default.
• W4379330255 hasConcept C71924100 @default.
• W4379330255 hasConcept C72563966 @default.
• W4379330255 hasConcept C86803240 @default.
• W4379330255 hasConceptScore W4379330255C104317684 @default.
• W4379330255 hasConceptScore W4379330255C121608353 @default.
• W4379330255 hasConceptScore W4379330255C126322002 @default.
• W4379330255 hasConceptScore W4379330255C142724271 @default.
• W4379330255 hasConceptScore W4379330255C143998085 @default.
• W4379330255 hasConceptScore W4379330255C191093355 @default.
• W4379330255 hasConceptScore W4379330255C204232928 @default.
• W4379330255 hasConceptScore W4379330255C2777542201 @default.
• W4379330255 hasConceptScore W4379330255C2779786085 @default.
• W4379330255 hasConceptScore W4379330255C2781187634 @default.
• W4379330255 hasConceptScore W4379330255C2781197716 @default.
• W4379330255 hasConceptScore W4379330255C30481170 @default.
• W4379330255 hasConceptScore W4379330255C526805850 @default.
• W4379330255 hasConceptScore W4379330255C530470458 @default.
• W4379330255 hasConceptScore W4379330255C55493867 @default.
• W4379330255 hasConceptScore W4379330255C71924100 @default.
• W4379330255 hasConceptScore W4379330255C72563966 @default.
• W4379330255 hasConceptScore W4379330255C86803240 @default.
• W4379330255 hasFunder F4320306239 @default.
• W4379330255 hasIssue "16_suppl" @default.
• W4379330255 hasLocation W43793302551 @default.
• W4379330255 hasOpenAccess W4379330255 @default.
• W4379330255 hasPrimaryLocation W43793302551 @default.
• W4379330255 hasRelatedWork W2019279330 @default.
• W4379330255 hasRelatedWork W2313360580 @default.
• W4379330255 hasRelatedWork W2350493697 @default.
• W4379330255 hasRelatedWork W2885255207 @default.
• W4379330255 hasRelatedWork W2972884351 @default.
• W4379330255 hasRelatedWork W2984545096 @default.
• W4379330255 hasRelatedWork W3026015583 @default.
• W4379330255 hasRelatedWork W4284961825 @default.
• W4379330255 hasRelatedWork W4362450825 @default.
• W4379330255 hasRelatedWork W2588285805 @default.
• W4379330255 hasVolume "41" @default.
• W4379330255 isParatext "false" @default.
• W4379330255 isRetracted "false" @default.
• W4379330255 workType "article" @default.